Navigation Links
InVitria Successfully Completes Beta Testing and Announces Commercial Launch of Optiferrin for Mammalian Cell Culture
Date:9/16/2009

Optiferrin shown to provide superior performance in cell culture and addresses the need for animal-free transferrin in many applications including Stem Cells, Primary Cells, Hybridoma Cells and Chinese Hamster Ovary (CHO) cells.

Fort Collins, CO (PRWEB) September 16, 2009 -- InVitria today announced the launch of Optiferrin, a high performance, well-defined and animal-free recombinant transferrin for use in mammalian cell culture. Optiferrin is a cell culture supplement which supports cell growth by regulating the amount of iron transported to the cell. Since iron is required for healthy cell culture performance, it is a critical component to reach optimal performance.

"Optiferrin has undergone extensive testing by our beta customers since June 2009. They have formulated Optiferrin into their cell culture media to provide maximum performance and they liked their results. We are delighted to be able to bring this sort of value to our customers through innovations like Optiferrin," said Scott Deeter, President & CEO of InVitria.

"Transferrin is nature's way to deliver iron in a non-toxic manner," said Dr. Steve Pettit, InVitria's Director of Cell Culture Development. "Our product development, along with beta customer results, confirmed that Optiferrin delivered optimal performance without any cell damage. This alleviates customer's concerns about animal-origin infectious contaminants or the headaches caused by addition of elemental iron and iron chelators in cell culture media," said Dr. Pettit.

Optiferrin is a complimentary product to InVitria's other cell culture supplement products, which include Cellastim, Lacromin, Zap-CHO and Zap-Hybridoma.

About InVitria
InVitria develops, manufactures and markets a portfolio of high performance and well defined cell culture media components and reagents used in bioprocessing, biopharmaceutical formulation, stem cell & regenerative medicine, life science research, medical devices and diagnostics.

For more information about InVitria's product line, contact us at info(at)InVitria(dot)com or call 1-800-916-8311.

# # #

Read the full story at http://www.prweb.com/releases/Optiferrin/recombinanttransferrin/prweb2895654.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. InVitria Cell Culture Product Line to Headline PEACe
2. InVitria Sponsors ESACT 2009 in Dublin, Ireland
3. InVitria to Present at BIO 2009 International Convention in Atlanta
4. InVitria Reveals Technology to Optimize Hybridoma Production Performance
5. InVitria Headlines Sponsorship of WilBio's Waterside Conference
6. InVitria Announces Launch of Recombinant Albumin for Diagnostics
7. InVitria's Cell Culture Media Components Showcased at WilBio's 2008 Cell Engineering Meeting
8. InVitria's Cellastim Delivers Superior Results in CHO Cell Culture
9. InVitria to Launch "BE FREE" Promotion at TERMIS '08 in San Diego
10. InVitria to Showcase its Innovative Cell Culture Components at American Society of Cell Biology Annual Meeting
11. InVitria to Present at WilBio's International Cell Engineering Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... ... 2016 , ... W.S. Badger Co. Inc ., the maker of certified ... as one of the best small businesses for new dads by Fatherly, the digital ... businesses providing progressive benefits to new parents on the organization’s 2016 Best Places ...
(Date:5/27/2016)... ... ... This campaign aims to provide a path to improved education and awareness ... change. , As nearly 795,000 Americans suffering from a new or recurrent stoke each ... an estimated 129,000 of these people dying from stroke, it’s become our nation’s fifth-leading ...
(Date:5/27/2016)... Texas (PRWEB) , ... May 27, 2016 , ... ... satisfying Army body fat composition regulations. This is the first time that Coolsculpting ... normally screened at least every six months to ensure they meet the prescribed body-fat ...
(Date:5/27/2016)... ... 2016 , ... Each year Standard Process Inc. ... this year’s Life University winner of a $2,500 scholarship from Standard ... Awards ceremony. , Outerbridge is approaching her last quarter at Life University in ...
(Date:5/26/2016)... ... 26, 2016 , ... There are many ways to cook a hot dog, ... that Americans prefer their dogs straight off the grill. Of the 90 percent of ... way to cook a hot dog, far outpacing other cooking methods such as steaming ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... Amarantus BioScience Holdings, Inc. (OTCQX: AMBS), ... and Orphan Diseases, today announced that President & CEO Gerald ... SeeThru Equity MicroCap Conference   Where: ... , NY When: Tuesday, May 31 st , ... Where: Grand Hyatt Hotel, 109 East 42 nd St, ...
(Date:5/26/2016)... 2016   Change Healthcare , a ... solutions and technology-enabled services designed to enable ... a strategic channel partnership with SourceMed, the ... and revenue cycle management services that empower ... clinics to optimize revenue, operational efficiency and ...
(Date:5/25/2016)... and GERMANTOWN, Maryland , May ... QGEN ; Frankfurt Prime Standard: QIA) today announced that ... with Therawis Diagnostics GmbH to develop and commercialize predictive assays ... market PITX2 as a marker to predict effectiveness of anthracycline ... "We are pleased to partner with Therawis, which ...
Breaking Medicine Technology: